Chargement en cours...

Treatment comparisons in the third MRC myelomatosis trial. Medical Research Council's Working Party on Leukaemia in Adults.

Results after an average follow-up of 3 years are presented on 485 patients in the 3rd MRC therapeutic trial in myelomatosis. The 353 non-azotaemic patients (199 now dead) were randomized between i.v. cyclophosphamide (CY) and oral melphalan with prednisone (M & P). THose treated with M & P...

Description complète

Enregistré dans:
Détails bibliographiques
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 1980
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2010576/
https://ncbi.nlm.nih.gov/pubmed/7006664
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!